Thymic stromal lymphopoietin is a key mediator of breast cancer progression

Purevdorj B. Olkhanud, Yrina Rochman, Monica Bodogai, Enkhzol Malchinkhuu, Katarzyna Wejksza, Mai Xu, Ronald E. Gress, Charles Hesdorffer, Warren J. Leonard, Arya Biragyn

Research output: Contribution to journalArticlepeer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'Thymic stromal lymphopoietin is a key mediator of breast cancer progression'. Together they form a unique fingerprint.

Medicine & Life Sciences